Provided by Tiger Trade Technology Pte. Ltd.

Integra Lifesciences

16.60
-0.1400-0.84%
Volume:347.95K
Turnover:5.75M
Market Cap:1.29B
PE:-178.27
High:17.00
Open:16.74
Low:16.39
Close:16.74
52wk High:20.49
52wk Low:8.70
Shares:77.89M
Float Shares:58.67M
Volume Ratio:0.64
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0931
EPS(LYR):-6.7400
ROE:-0.70%
ROA:2.82%
PB:1.24
PE(LYR):-2.46

Loading ...

Integra LifeSciences Holdings (IART), Why Is It Getting Attention Now?

Simply Wall St.
·
Aug 22

How Earnings Turnaround And FX-Hit Outlook At Integra LifeSciences (IART) Has Changed Its Investment Story

Simply Wall St.
·
Aug 10

Integra Lifesciences (IART) Receives a Hold from BMO Capital

TIPRANKS
·
Jul 30

Wells Fargo Sticks to Their Hold Rating for Integra Lifesciences (IART)

TIPRANKS
·
Jul 30

Integra Lifesciences Holdings Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 29

GUIDANCE: (IART) Integra LifeSciences Expects 2026 Revenue Range $1.65B - $1.70B, vs. FactSet Est of $1.68B

MT Newswires Live
·
Jul 29

GUIDANCE: (IART) Integra LifeSciences Expects 2026 Adjusted EPS Range $2.40 to $2.50, vs. FactSet Est of $2.45

MT Newswires Live
·
Jul 29

Integra LifeSciences Q2 Revenue Slightly Beats, Adjusted EPS Tops Estimates

Reuters
·
Jul 29

Integra LifeSciences Q2 FY26 GAAP EPS Turns to Profit at $0.06; Revenue Rises 0.8% to $418.8 Million

Reuters
·
Jul 29

Integra Lifesciences Q2 Adjusted EPS USD 0.56 Vs. IBES Estimate USD 0.48

Reuters
·
Jul 29

Integra Lifesciences - Guides Q3 2026 Revenue $410 Mln-$425 Mln, Adj EPS $0.53-$0.61

THOMSON REUTERS
·
Jul 29

Integra Lifesciences - Reaffirms 2026 Organic Revenue Growth Guidance 0.8%-3.3% and Adj EPS $2.40-$2.50

THOMSON REUTERS
·
Jul 29

Integra Lifesciences Q2 EPS USD 0.06

THOMSON REUTERS
·
Jul 29

Integra Lifesciences Q2 Adjusted Ebitda USD 78.4 Million

THOMSON REUTERS
·
Jul 29

Integra Lifesciences Holdings Corp Q3 Shr View $0.56, REV View $418.1 Mln

THOMSON REUTERS
·
Jul 29

Integra LifeSciences Initiated at Neutral by UBS

Dow Jones
·
Jul 29

UBS Initiates Coverage on Integra LifeSciences With Neutral Rating, $19 Price Target

MT Newswires Live
·
Jul 28

Integra Lifesciences Holdings Corp : UBS Initiates Coverage with Neutral Rating; Target Price $19

THOMSON REUTERS
·
Jul 28

Integra LifeSciences initiated with a Neutral at UBS

TIPRANKS
·
Jul 28

Integra LifeSciences Holdings (IART) Rebound Puts Its Turnaround Valuation Narrative Back In Focus

Simply Wall St.
·
Jul 27